Clinical and epidemiological characteristics and outcomes of patients hospitalized for COVID-19 in Douala, Cameroon.
Adult
Aged
COVID-19
/ epidemiology
Cameroon
/ epidemiology
Female
Hospitalization
/ statistics & numerical data
Humans
Intensive Care Units
/ statistics & numerical data
Length of Stay
/ statistics & numerical data
Male
Middle Aged
Real-Time Polymerase Chain Reaction
Retrospective Studies
Reverse Transcriptase Polymerase Chain Reaction
Young Adult
COVID-19 Drug Treatment
COVID-19
Cameroon
clinical characteristics
epidemiology
outcomes
Journal
The Pan African medical journal
ISSN: 1937-8688
Titre abrégé: Pan Afr Med J
Pays: Uganda
ID NLM: 101517926
Informations de publication
Date de publication:
2021
2021
Historique:
received:
05
02
2021
accepted:
22
02
2021
entrez:
9
6
2021
pubmed:
10
6
2021
medline:
16
6
2021
Statut:
epublish
Résumé
the coronavirus disease (COVID-19) is a disease that originated from Wuhan in December 2019. It rapidly spread across the globe causing high mortality especially among the elderly. Africa though not spared has limited studies regarding its effects on its population. We therefore sought to describe the epidemiological and clinical characteristics of COVID-19 in Douala, Cameroon. we conducted a single-centre, retrospective, and observational study by reviewing records of patients managed for COVID-19 between the 8 we analyzed 282 case files, 192 were males (M: F=2: 1). The mean age was 52 (+/- 15) years. Hypertension and diabetes accounted for 75% of the chronic medical conditions identified. Main presenting complaints were dyspnea, cough, asthenia, and fever (55-60%). Radiographic analysis showed a ground-glass appearance in 85% of cases. Chloroquine/Hydroxychloroquine was the most (91.8%) frequently used drug in management protocols, 35% needed oxygen supplementation while 6 patients were intubated. Severe pneumonia (11.3%) was the commonest complication. They were 91 admissions in the intensive care unit. The average length of hospital stay was 10 (+/- 5) days. The mortality rate was 32%. our findings are concordant with universally reported data of COVID-19 hospitalised patients. These parameters are essential in designing effective prevention and control programs aimed at reducing the impact of the COVID-19 pandemic particularly in countries with limited resources.
Identifiants
pubmed: 34104294
doi: 10.11604/pamj.2021.38.246.28169
pii: PAMJ-38-246
pmc: PMC8164425
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
246Informations de copyright
Copyright: David Mekolo et al.
Déclaration de conflit d'intérêts
The authors declare no competing interests.
Références
Am J Trop Med Hyg. 2020 Dec;103(6):2419-2428
pubmed: 33009770
Pan Afr Med J. 2020 Jul 24;35(Suppl 2):122
pubmed: 33282077
Lancet Infect Dis. 2020 Dec;20(12):1367-1368
pubmed: 32618280
Pan Afr Med J. 2020 Jun 15;35(Suppl 2):77
pubmed: 33623601
Trop Med Int Health. 2020 Mar;25(3):278-280
pubmed: 32052514
Rev Francoph Lab. 2020 Nov;2020(526):40-47
pubmed: 33163103
Eur J Radiol. 2020 May;126:108961
pubmed: 32229322
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
J Community Health. 2021 Jun;46(3):457-470
pubmed: 32638198
Lancet Respir Med. 2020 May;8(5):475-481
pubmed: 32105632
JAMA Intern Med. 2020 Oct 1;180(10):1345-1355
pubmed: 32667669
Ethiop J Health Sci. 2020 Sep;30(5):645-652
pubmed: 33911824
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Pan Afr Med J. 2020 May 13;35(Suppl 2):34
pubmed: 33623559
Ghana Med J. 2020 Dec;54(4 Suppl):5-15
pubmed: 33976436
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Lancet. 2020 Jun 6;395(10239):1763-1770
pubmed: 32442528
Monaldi Arch Chest Dis. 2020 Apr 10;90(1):
pubmed: 32290644
Pan Afr Med J. 2020 Sep 11;37(Suppl 1):7
pubmed: 33294108
Chin Med J (Engl). 2020 May 5;133(9):1025-1031
pubmed: 32044814